1 strategies for vaccinating children against
novel influenza A (H1N1) as well as seasonal influenza.
2 A large outbreak of
novel influenza A (H1N1) virus (swine origin influenza v
3 In the spring of 2009, a
novel influenza A (H1N1) virus (swine origin influenza v
4 This recent outbreak of infection with a
novel influenza A (H1N1) virus also demonstrates the imp
5 In the spring of 2009, a
novel influenza A (H1N1) virus emerged in North America
6 A
novel influenza A (H1N1) virus has spread rapidly across
7 atory during a springtime 2009 outbreak of a
novel influenza A (H1N1) virus in New York State is desc
8 us on GBS when monovalent vaccines against a
novel influenza A (H1N1) virus of swine origin were intr
9 Given the current worldwide threat of
novel influenza A (H1N1), with an estimated R of 1.4-1.6
10 The emergence of
novel influenza A H1N1 and highly pathogenic avian influ
11 and recommendations for vaccination against
novel influenza A have emerged as well.
12 virus host factor that may be targeted as a
novel influenza A therapeutic strategy.
13 We report the isolation of a
novel influenza A virus (H2N2) cultured in 2013 from a h
14 The emergence of the
novel influenza A virus (IAV) H7N9 since 2013 has caused
15 hat poor performance in the detection of the
novel influenza A virus 2009 H1N1 should preclude their
16 , understanding how orthomyxoviruses such as
novel influenza A virus reassortants and/or mutants emer
17 provide partial protection to humans against
novel influenza A virus strains introduced into humans f
18 efficiently among humans are essential for a
novel influenza A virus to cause a pandemic.
19 Human infections with
novel influenza A viruses are of global public health co
20 re chemoprophylaxis of human infections with
novel influenza A viruses associated with severe human i
21 Novel influenza A viruses of the H7N9 subtype [A(H7N9)]
22 The
novel influenza A viruses of the H7N9 subtype [A(H7N9)],
23 f influenza and monitor for the emergence of
novel influenza A viruses.
24 The 2009
novel influenza A(H1N1) pandemic period was excluded fro
25 In March 2013, a
novel influenza A(H7N9) virus emerged in China as an une
26 Two
novel influenza A-like viral genome sequences have recen
27 In this report, we used a
novel Influenza A/California/04/09 (H1N1) reporter virus
28 data available describing human immunity to
novel influenza A/H7N9.
29 phere winter of 2003-2004 the emergence of a
novel influenza antigenic variant, A/Fujian/411/2002-lik
30 does this work describe the development of a
novel influenza assay, it also demonstrates the power of
31 tion options should initial containment of a
novel influenza outbreak fail, using Great Britain and t
32 Because of the continuous threat of
novel influenza outbreaks, it is essential to gather fur
33 Following the detection of a
novel influenza strain A(H7N9), we modeled the use of an
34 Humans, upon infection with a
novel influenza strain, produce Abs against older viral
35 rrectly identify both well-characterized and
novel influenza strains offers the possibility to integr
36 In the context of recently emerged
novel influenza strains through reassortment, avian infl
37 e valid predictions of pandemic potential of
novel influenza strains, though results should continue
38 ts in studying the transmission potential of
novel influenza strains.
39 ody produced in response to vaccines against
novel influenza strains.
40 In theory, a similar
novel influenza subtype could be controlled.
41 In the pig, genetic reassortment to create
novel influenza subtypes by mixing avian, human, and swi
42 ccur in coincident temporal association with
novel influenza vaccination.
43 The
novel influenza vaccine MVA-NP+M1 is designed to boost c
44 replication-incompetent NS2-knockout VLPs as
novel influenza vaccines and perhaps also as vectors to
45 lly catastrophic influenza pandemic requires
novel influenza vaccines that are safe, can be produced
46 Direct comparisons of similar doses of a
novel influenza virus antigen administered by the intrad
47 The frequency of
novel influenza virus detection is increasing, and human
48 nd transmission of and approaches to prevent
novel influenza virus infections.
49 The potential for
novel influenza virus lineages to evolve within Africa w
50 A-315675 is a
novel influenza virus NA inhibitor that has potent enzym
51 rge-scale sequencing effort, we identified a
novel influenza virus of wholly human origin that has be
52 Over the past 2 decades, several
novel influenza virus proteins have been identified that
53 Here we describe a
novel influenza virus sequence feature variant type (Flu
54 asurement used for identifying antigenically
novel influenza virus strains.
55 Influenza D virus (FLUDV) is a
novel influenza virus that infects cattle and swine.
56 increase the chances for the emergence of a
novel influenza virus with pandemic potential.
57 A
novel influenza virus, tentatively classified as influen
58 ldren are susceptible to infection with this
novel influenza virus.
59 gations for future pandemics or outbreaks of
novel influenza viruses among humans.
60 other respiratory pathogens will help detect
novel influenza viruses and inform and develop targeted
61 Influenza pandemics arise when
novel influenza viruses are introduced into a population
62 eems wise to conduct better surveillance for
novel influenza viruses at Chinese live bird markets.
63 ual circulation of seasonal influenza, while
novel influenza viruses invade the human population to c
64 blic health threat posed by the emergence of
novel influenza viruses necessitates the ability to rapi
65 The emergence of
novel influenza viruses that cause devastating human dis
66 to monitor H7N9 and detect other unexpected
novel influenza viruses that may emerge.
67 ant parameter in evaluating the virulence of
novel influenza viruses, and findings are extrapolated t
68 in-specific or cross-protective vaccines for
novel influenza viruses.
69 e future surveillance and risk assessment of
novel influenza viruses.
70 dren are highly vulnerable to infection with
novel influenza viruses.
71 says commonly used to identify antigenically
novel influenza viruses.
72 ddress humans as hosts for the generation of
novel influenza viruses.